Fresenius Medical Care

• Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease

  Fees or honoraria, 31 Aug 2026

• More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases

  Consulting or advice, Fees or honoraria, Grants or research support, 15 Feb 2026

• Protein Intake and Mortality in Older Adults With Chronic Kidney Disease

  Fees or honoraria, 1 Aug 2024

Sources: pubmed.ncbi.nlm.nih.gov

• Systematic Review and Meta-analysis of the Association of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Dementia in Patients with Type 2 Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Cost-Effectiveness of SGLT2i plus GLP-1RAs vs. SGLT2i in Patients with Chronic Kidney Disease

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025